WithdrawnEarly Phase 1

Intralesional Tetracycline Injection in the Treatment of Chalazia

Stopped: Investigator left the institution

United States0Started 2014-03

Plain-language summary

The investigators propose a study to investigate the role of tetracycline injection into chalazia versus observation alone. The investigators hypothesize tetracycline injection will result in a significant decrease in lesion size when compared to observation alone.

Who can participate

Age range18 Years

SexALL

See this in plain English?

AI-rewrites the medical criteria so a patient or caregiver can understand them. Always confirm with the trial site.

Inclusion Criteria: * Age older than 18 years * Not pregnant * Chalazia of greater than 1 week duration * Not allergic to tetracycline or its derivatives * Not currently taking tetracycline or not taking them in the past 3 months Exclusion Criteria: * Age less than 18 years old * Pregnancy * Chalazia of less than 1 week duration * Allergies to tetracycline or its derivatives * Currently taking tetracyclines or have taken them in the past 3 months

What they're measuring

Lesion size

Timeframe: 4 weeks

Trial details

NCT IDNCT01763437

SponsorThe Cleveland Clinic

Sponsor typeOTHER

Study typeINTERVENTIONAL

Primary completion2015-03

View on ClinicalTrials.gov More Chalazia trials